focus -WSS

focus

author：Wikipedia 2025-09-30 09:30:35 - browse：92585

Pascal Soriot 2019 — Pascal Soriot has served as CEO of AstraZeneca since 2012. Win McNamee/Getty Images

CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030.

Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs. It would also require outpacing the targets laid out by AstraZeneca’s large pharma peers.

But at an investor day here at the company’s shiny new Discovery Centre, CEO Pascal Soriot opened his presentation by bringing up the goal set by the company a decade ago — $45 billion in revenue by 2023. The company faced some declines early in that period, but after surging in the past few years, it hit that target, bringing in $45.8 billion last year. Its recent growth has also propelled the company’s share price.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 4 missing after record

WSS

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Why Marc Tessier

Where does female orgasm come from? Scientists think they know

Transgender women dream of pregnancy via uterus transplants

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Sophia Smith scores twice for US in in 3

Tori Bowie and the unacceptable rates of Black maternal death

How a key Senate committee is planning to regulate PBMs

The cancer drug shortage isn’t new — and neither are the solutions

Doctors have an ethical obligation to be advocates

Continuity nursing helped my family in our darkest PICU moments

What Henrietta Lacks's story taught me about my role as a doctor

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Clinic falsely told dozens they had Alzheimer's, suits say

entertainment

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Thousands protest mob assault of women who were paraded naked in remote Indian border state

The response to Covid

The response to Covid

Florida babysitter arrested over hot car death, authorities say

Wikipedia

explore

focus

hotspot